Integra Lifesciences Holdings CorpIART
Price$16.09Intrinsic value$35.94123% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $35.94median of 3 methodsbased on filings through 30 Jun 2026
Market Price $16.09Price as of 1 Oct 2026
Margin of Safety +123.4%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 14.7% (near-term consensus, capped) · years 2–5: 7.0%/yr (balance of the path).8.5% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 67.3%Yr 77.6%Yr 87.9%Yr 98.2%Yr 108.5%
7.0% → 8.5%
Years 11–20: glide to long-run rate
Per-year rates
Yr 118.0%Yr 127.4%Yr 136.9%Yr 146.3%Yr 155.8%Yr 165.2%Yr 174.7%Yr 184.1%Yr 193.6%Yr 203.0%
8.5% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 10.0%
Volatility vs market (adjusted beta)1.13

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetIntegra Lifesciences Holdings CorpIARTHealth Care
Valuation
P/E—
P/S0.7×
P/B1.1×
EV / Revenue1.0×
EV / EBITDA—
Profitability
Gross margin50.9%
Operating margin-30.2%
Net margin-0.4%
FCF margin1.6%
Returns
ROE-0.7%
ROA-0.2%
ROIC-0.5%
Growth
Revenue growth (YoY)2.3%
5-yr fwd EPS growth8.5%
Financial strength
Debt / Equity0.68×
Current ratio3.60×
Altman Z-Score1.3
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.